News & Events about Theseus Pharmaceuticals Inc.
Theseus Pharmaceuticals Initial Dose Escalation Results from Ongoing Phase 1/2 Trial of THE-630 Accepted for Online Publication at 2023 ASCO Annual Meeting Theseus Pharmaceuticals Initial Dose Escalation Results from Ongoing Phase 1/2 Trial of THE-630 Accepted for Online Publication at 2023 ASCO...
Market News Video
5 months ago
In trading on Thursday, shares of Theseus Pharmaceuticals Inc (THRX) crossed above their 200 day moving average of 7.32, changing hands as high as 8.30 per share. Theseus Pharmaceuticals Inc shares are currently trading up about 13% on the day...
Theseus Pharmaceuticals to Participate at Upcoming September Investor Conferences Theseus Pharmaceuticals to Participate at Upcoming September Investor Conferences PR Newswire CAMBRIDGE, Mass., Sept. 6, 2022 CAMBRIDGE, Mass., Sept. 6, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ...
Theseus Pharmaceuticals to Participate Virtually in Wedbush PacGrow Healthcare Conference Theseus Pharmaceuticals to Participate Virtually in Wedbush PacGrow Healthcare Conference PR Newswire CAMBRIDGE, Mass., Aug. 3, 2022 CAMBRIDGE, Mass., Aug. 3, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc...
Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors PR Newswire CAMBRIDGE, Mass., May 18, 2022 CAMBRIDGE, Mass., May 18, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a...